Navigation Links
Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial

ure studies with the FDA. We are hopeful that these results will enable us to move forward to a pivotal phase III study earlier than originally anticipated."

These results are important not only for the development and approval path for HyCAMP(TM) itself but they provide validation of the technology platform. The HyACT(TM) platform is an extremely flexible formulation technology as it can be used with virtually any intravenously administered anti-cancer treatment. We have successfully completed Phase I clinical studies on HyACT(TM) formulations of two other chemotherapy drugs, doxorubicin and 5- flurouracil. Encouraging preclinical data has also been obtained on a number of other cytotoxics. More recently, we have demonstrated in preclinical studies that HyACT(TM) can also be used to significantly enhance the efficacy of newer targeted antibody therapies such as Avastin(TM) and Erbitux(TM) In the case of generic drugs or drugs close to patent expiry, the HyACT(TM) formulation may provide a means for companies to differentiate their products from other competitors in the market place, and thereby build product value.

HyCAMP(TM) and the proprietary formulation technology, HyACT(TM), were obtained following the successful acquisition of Melbourne based oncology company Meditech Research Limited in 2006. "The Phase II clinical results provide proof of concept for the HyACT(TM) platform. We expect this technology to build substantial value for shareholders, not only with HyCAMP(TM), but with other oncology drugs as well" Dr Ramsdale said.

Before HyCAMP(TM) can be marketed in the US, the drug needs to successfully complete a Phase III study, and receive marketing approval from the US FDA.

Alchemia wishes to acknowledge the commitment and thank the patients who volunteered to participate in this trial, and to acknowledge and thank the investigators, study research personnel and nursing staff at the 10 clinical sites across Australia who looked a
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:5/27/2015)... 2015  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to ... Chief Financial Officer, will present at the Jefferies 2015 Global ... in New York City . ... from the Cambrex website at www.cambrex.com in the ... be available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... , May 27, 2015  Novartis will highlight ... 21 medicines and 11 investigational compounds across more ... Society of Clinical Oncology (ASCO) Annual Meeting, May ... Hematology Association (EHA), June 11-14. Data will demonstrate ... types, including melanoma, lung, breast, kidney and blood ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... the "Research and Future Development Trend Forecast of ... At present, there are 35,600 dialysis centers ... ratio are large due to the different regional operating ... centers in other Asian countries are operated by state-owned ...
Breaking Medicine Technology:Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 2Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 3Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 4Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 5Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 6Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 7Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 8China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... and BRUSSELS, June 30, 2011 UCB and Harvard ... signing ceremony that took place in Boston last night ... of Belgium. (Photo: http://photos.prnewswire.com/prnh/20110630/NY28450 ) ... bridge between industry and academia, with Harvard scientists continuing ...
... 2011 Company remains committed to speeding ... R&D pipeline boasts 70 potential medicines in clinical development, including 33 ... least ten potential new medicines in Phase III by the end ... areas such as neuroscience, diabetes and oncology, as well as new ...
Cached Medicine Technology:UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 2Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 3Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 4Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 5Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 6Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 7Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 8Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 9Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 10Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 11Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 12Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 13Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 14Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 15Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 16
(Date:5/27/2015)... (PRWEB) May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com ... with a cutting-edge test that makes it easier for patients ... skin type. , Dr. Sejal Shah is a cosmetic ... in NYC to offer the test. This revolutionary DNA test ... associated with skin aging: , 1. Firmness and ...
(Date:5/27/2015)... Decorview , a leading seller of custom ... advice to homeowners looking to , combat light pollution ... by streetlights, outdoor signs, full moons and other exterior ... Rush, VP of sales and merchandising for Decorview. “Just ... recently installed LED streetlights– the blue glare from these ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Splashtop Inc., the ... addition to its screen mirroring and extended display product line ... a conference room, classroom, or family room, users can instantly ... TV / display connecting to an Apple TV, a computer, ... TV, Amazon Fire TV Stick, or the Google Nexus Player. ...
(Date:5/27/2015)... The news is full of companies getting fined, ... or appropriate training: an automobile manufacturer, a store in ... in Texas and the list goes on. The Feds ... to improper training and documentation (Osha.gov). eLeaP Learning ... new Supervisor feature which provides a powerful tool for ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Altec Products, ... solutions, announced today their Premier Sponsorship of Connections 2015. ... Glendale Hilton on Thursday, May 28th and will deliver ... as well as the roadmap to get there. ... specializing in the sale, installation and support of Intacct ...
Breaking Medicine News(10 mins):Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 3Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3
... expands its virtual medical affairs services for food, beverage, healthcare and ... ... 2008 -- Award-winning Academic Network LLC, a leading medical and health ... General Woodie Kessel, MD, MPH, has joined the firm as Senior ...
... and tens of thousands of jobs being created every month, the medical ... layoff announcements that tend to shock the average job seeker. , ... ... in health care continued to rise through the month of May, with ...
... the largest health community on the web, and HealthCare.com partner ... , ... San Francisco, CA and ... ), the largest health community on the web, and HealthCare.com, ...
... Woodland Hills, CA, provides a comprehensive drug rehab program ... abuse treatment and a supportive, sober environment. The ... abuse treatment for young adults. Sober College gives ... development of life skills while they complete a comprehensive ...
... Thomas Edison deliberately mined his unconscious for patent development ... As the brick fell, he woke with new insights, ... in psychology and forty years experience with the unconscious ... researchers and provides them with techniques to access it. ...
... Council (NIC) has completed a new classified assessment that ... the next 20 years by causing political instability, mass ... other resources in specific countries. The House Intelligence Committee ... the main findings. , ...
Cached Medicine News:Health News:Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor 2Health News:Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor 3Health News:The MedZilla Report: May 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: May 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:MedHelp Launches Healthcare Provider Search Powered by HealthCare.com 2Health News:MedHelp Launches Healthcare Provider Search Powered by HealthCare.com 3Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 2Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 3Health News:California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment 4Health News:Researchers Revisit Edison's Method of Generating Olympic Level Ideas via Unique New Corporate Seminar 2Health News:Researchers Revisit Edison's Method of Generating Olympic Level Ideas via Unique New Corporate Seminar 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3
... BVM 6500 enables physicians ... determine UEBW (ultrasound estimated ... volume using 3-dimensional V-mode ... was designed to assist ...
... Bard Collagen Implant, the world's leading bulking ... for the treatment of Stress Urinary Incontinence ... surrounding urethral tissue to aid coaptation in ... body's own structure, Contigen Bard Collagen Implant ...
... The Titan™ Inflatable Penile Prosthesis ... designed to be surgically implanted ... management of erectile dysfunction (also ... provides the patient with voluntary ...
... The AMS 650™ and 600M™ malleable ... many patientsespecially those with limited dexterity. These ... allows the patient to position them in ... make the penis rigid enough for sexual ...
Medicine Products: